Court upholds ‘Pharma Bro’ Martin Shkreli’s conviction

National

FILE – In this Thursday, July 27, 2017, file photo, Martin Shkreli, center, leaves federal court with his attorney Benjamin Brafman, left, in New York. A federal appeals court on Thursday, July 18, 2019 has upheld the securities fraud conviction against the former drug company CEO. (AP Photo/Julie Jacobson, File)

NEW YORK (AP) — A federal appeals court has upheld the securities fraud conviction against former drug company CEO Martin Shkreli.

Shkreli was sentenced to seven years in prison last year for looting a drug company he founded, Retrophin, of $11 million to pay back investors in two failed hedge funds he ran.

A message requesting comment was emailed to Shkreli’s legal team Thursday.

Before his arrest, Shkreli was best known for buying the rights to a lifesaving drug at another company in 2014 and raising the price from $13.50 to $750 per pill.

He also gained notoriety for attacking critics on social media under the moniker “Pharma Bro.” He was barred from Twitter for posts about a female journalist.

Copyright 2019 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories

More trending stories

Dowloand Our News Apps

FREE News & Weather Apps

Get the StormTracker13 Weather App

Download Now:

Get the News13 News App

Download Now: